Pre-Open Stock Movers 12/14: (AKBA) (DEST) (TSL) Higher; (ATRA) (NWL) (GPRO) Lower (more...)
Tweet Send to a Friend
Atara Biotherapeutics, Inc. (Nasdaq: ATRA) 42.8% LOWER; announced results from its Phase 2 proof-of-concept clinical trial for PINTA 745 for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
